ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 373980 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 373980; 2) Community: the network communities that were significantly associated with the response to NSC 373980; 3) Molecule: the relationships between components within communities and NSC 373980; 4) MDR: the compounds that were significantly associated with the NSC 373980.

NSC Compound Enrichment Correlation
NSC 758662 Lovastatin [USAN] 0.0133299224082802 -0.20377275
NSC 760979 Null 0.0133299224082802 0.45128059
NSC 146268 as-Triazine-3,5(2H,4H)-dione, 2-.beta.-D-ribofuranosyl-3-thio- 0.0133299224082803 0.52363427
NSC 163664 Arsinothious acid, dimethyl-, 2,4-pyrimidinediyl ester (9CI) 0.0133299224082803 0.33127836
NSC 335753 HELIANGOLIDE 0.0133299224082803 0.56319054
NSC 337851 Pregna-1,4-diene-3,11,20-trione, 21-[[[[3,6-bis(dimethylamino)-9-acridinyl]thio]acetyl]oxy]-17-hydroxy- 0.0133299224082803 0.57499976
NSC 113452 Null 0.0135714101922724 0.31063107
NSC 143093 Acetylkidamycin 0.0135714101922724 0.513673
NSC 187546 Ethanimidamide, 2-chloro-N-(tricyclo[3.3.1.1(3,7)]dec-1-ylmethyl)-, monohydrochloride 0.0135714101922724 0.62735713
NSC 326408 Rocaglamide (FR AGLAIA ELLIPTIFOLIA) 0.0135714101922724 0.46936774
Total:137  Current:59    [First] [Prev] [Next] [Last]